Loading clinical trials...
Loading clinical trials...
Lung fluid absorption disorders are largely mediated by transepithelial Na+ reabsorption through alpha epithelial sodium channels (α-ENaCs) in alveolar epithelial cells. Increasing evidence has demonstrated that these lung disorders might be an important cause of neonatal respiratory distress syndrome (NRDS) by influencing gas exchange or surfactant function, particularly in near-term and term infants. The SCNN1A gene, which encodes the α-ENaC, might predispose infants to NRDS. To explore whether the single-nucleotide polymorphisms (SNPs) of SCNN1A are associated with NRDS, we conducted a case-control study to investigate the NRDS-associated loci in Han Chinese infants. Seven target SNPs were selected from the SCNN1A gene and were genotyped using the improved multiplex ligase detection reaction (iMLDR).
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
Yes
Department of pediatrics, Daping Hospital, The Third Military Medical University
Chongqing, Chongqing Municipality, China
Start Date
January 1, 2012
Primary Completion Date
June 1, 2014
Completion Date
December 1, 2014
Last Updated
January 7, 2015
249
ACTUAL participants
no intervention
OTHER
Lead Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
NCT07235345
NCT02999165
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT02112513